By [Your Name/Editorial Desk]
July 29, 2026
For many college students, sorority philanthropy is a meaningful but often abstract commitment—a series of bake sales, 5K runs, and awareness campaigns designed to support distant causes. For Lizzy Burke, a 2014 initiate of Alpha Epsilon Phi (AEPhi) at Boston University, that commitment was grounded in personal history. Her mother, a breast cancer survivor diagnosed at 42, had instilled in her the importance of vigilance. Yet, even as Burke championed the mission of Sharsheret—a national non-profit organization supporting Jewish women and families facing breast and ovarian cancer—she could not have anticipated that the organization would one day serve as her own personal lifeline.
As Burke prepares to run the 2026 TCS New York City Marathon as a member of Team Sharsheret, her journey serves as a powerful testament to the intersection of grassroots advocacy, medical empowerment, and the critical need for hereditary cancer support networks.
The Chronology of a Shared Mission
Burke’s relationship with Sharsheret has evolved through three distinct phases: the advocate, the supporter, and the beneficiary.
Phase I: The Campus Advocate (2014–2017)
During her undergraduate years, Burke viewed Sharsheret through the lens of community service. AEPhi’s national partnership with the organization provided a framework for Burke to channel her family’s experience into action. At the time, her involvement was rooted in empathy for those facing diagnoses, but the science of hereditary cancer remained an external reality—something she supported but did not yet inhabit.
Phase II: The Athlete and Witness (2018–2019)
The connection deepened in 2018 when Burke and her sister, Maggie, joined Team Sharsheret for the TCS New York City Marathon. The experience of crossing the finish line cemented her commitment to the cause. It was a period of high spirits and physical challenge, yet the specter of cancer still felt like a challenge for "others" to overcome.
Phase III: The Personal Reality (2020–Present)
In 2020, the narrative shifted entirely. After undergoing genetic testing, Burke received the news that she carried the BRCA1 gene mutation. The mutation, which significantly increases the risk of developing breast and ovarian cancer, transformed the abstract statistics of her youth into a pressing medical roadmap. Following years of monitoring, Burke made the life-altering decision to undergo multiple risk-reducing surgeries, culminating in a double mastectomy in the fall of 2024.
Supporting Data: The Vital Importance of Hereditary Awareness
Burke’s story highlights a growing trend in public health: the proactive management of hereditary cancer risks. According to the National Cancer Institute, individuals with a BRCA1 or BRCA2 mutation face a substantially higher lifetime risk of breast and ovarian cancer compared to the general population.
Sharsheret plays a pivotal role in this landscape by providing specialized resources that bridge the gap between clinical diagnosis and emotional well-being. For young women like Burke, the challenges of navigating surgical decisions, early menopause, and body image are profound.
The "Sharsheret Effect"
The organization’s impact is measured not just in research funding, but in tangible, human-centric support:
- Peer Support Networks: Connecting women at similar life stages to reduce the isolation inherent in a cancer diagnosis.
- Pre-Surgery Kits: Providing practical tools to help patients navigate the logistical and physical challenges of recovery.
- Psychosocial Guidance: Offering professional counseling to help patients process the trauma of preventative surgery.
Burke’s testimony underscores the necessity of these services. When she faced unexpected complications during her 2024 recovery, the organization’s responsiveness—characterized by small, compassionate gestures like providing a bathrobe—served as a bridge between clinical care and human comfort.
Implications for Health Policy and Personal Advocacy
Today, Burke serves in a professional capacity as a health policy advisor for Senate Democratic Leader Chuck Schumer. This role has given her a broader vantage point on the systemic issues facing patients today. Her work in the halls of Congress informs her belief that access to information and care is a fundamental human right.
"Every day, I’m reminded how important access to information, care, and support can be in helping people make informed decisions about their health," Burke notes. Her transition from an advocate in a sorority house to a policymaker in Washington illustrates the long-term impact of early exposure to philanthropic work.
The Power of Informed Decision-Making
The implications of Burke’s advocacy are two-fold:
- Normalization of Testing: By sharing her BRCA1 journey, she works to destigmatize genetic testing, encouraging more families to understand their medical history.
- Policy Advocacy: Her professional life is dedicated to ensuring that the systems supporting patients—insurance coverage for genetic testing, access to specialists, and funding for research—are robust and equitable.
The 2026 Marathon: A Symbol of Gratitude
As November 2026 approaches, Burke is training not for personal glory, but as a symbolic gesture of gratitude. Running 26.2 miles is a physical manifestation of the endurance required to navigate a hereditary cancer diagnosis.
"This race is about so much more than running," Burke explains. "It’s about helping ensure that more individuals and families know their hereditary cancer risk, have access to genetic education and testing when appropriate, and find the same compassionate support that made such a difference in my own journey."
Her fundraising goal for the marathon is part of a larger, systemic effort to ensure that Sharsheret remains a sustainable resource for the next generation. By mobilizing her personal and professional networks, she is turning her experience into a blueprint for others to follow.
Conclusion: Awareness as a Lifeline
The story of Lizzy Burke is one of continuity. It begins with the camaraderie of a college sorority and matures into a sophisticated, life-long commitment to health equity. It serves as a reminder that cancer awareness is not merely a seasonal campaign, but a continuous, often invisible, battle that requires constant support and community engagement.
For those watching her progress toward the finish line this November, the message is clear: the support systems we build today—whether through campus organizations or national non-profits—are the foundations upon which we survive the trials of tomorrow.
As Burke returns to the streets of New York, she carries with her not just the miles behind her, but the collective hope of the families she represents. Her journey confirms that while the medical diagnosis of a genetic mutation may be an individual experience, the process of healing and advocacy is a collective one.
For those interested in supporting Lizzy Burke’s run or learning more about the services provided by Sharsheret, please visit her fundraising page. To learn more about genetic testing and hereditary cancer risk, please consult your primary care physician or a genetic counselor.
About the Author
